Kamada (KMDA) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Kamada

NASDAQ | KMDA

6.33

USD

-0.385 (-5.74%)

AT CLOSE (AS OF Apr 3, 2025)

$386M

MARKET CAP

26.84

P/E Ratio

0.25

EPS

$8.9

52 Week High

$4.6

52 Week Low

LIFE SCIENCES

Sector

KMDA Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

KMDA Technicals

Tags:

KMDA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$70M
Total Revenue	$161M
Cost Of Revenue	$91M
Costof Goods And Services Sold	$91M
Operating Income	$20M
Selling General And Administrative	$20M
Research And Development	$15M
Operating Expenses	$50M
Investment Income Net	-
Net Interest Income	$1.5M
Interest Income	$2.1M
Interest Expense	$660K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$14M
Income Before Tax	$13M
Income Tax Expense	-$1.1M
Interest And Debt Expense	-
Net Income From Continuing Operations	$14M
Comprehensive Income Net Of Tax	-
Ebit	$14M
Ebitda	$28M
Net Income	$14M

Revenue & Profitability

Earnings Performance

KMDA Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$372M
Total Current Assets	$184M
Cash And Cash Equivalents At Carrying Value	$78M
Cash And Short Term Investments	$78M
Inventory	$79M
Current Net Receivables	-
Total Non Current Assets	$188M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$102M
Intangible Assets Excluding Goodwill	$102M
Goodwill	$30M
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$3.9M
Other Non Current Assets	-
Total Liabilities	$113M
Total Current Liabilities	$49M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$1.6M
Total Non Current Liabilities	$63M
Capital Lease Obligations	$11M
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$11M
Other Current Liabilities	$20M
Other Non Current Liabilities	$53M
Total Shareholder Equity	$259M
Treasury Stock	-
Retained Earnings	-$26M
Common Stock	$15M
Common Stock Shares Outstanding	$55M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$48M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$14M
Capital Expenditures	$11M
Change In Receivables	-
Change In Inventory	$9.7M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$14M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$14M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$70M
Total Revenue	$161M
Cost Of Revenue	$91M
Costof Goods And Services Sold	$91M
Operating Income	$20M
Selling General And Administrative	$20M
Research And Development	$15M
Operating Expenses	$50M
Investment Income Net	-
Net Interest Income	$1.5M
Interest Income	$2.1M
Interest Expense	$660K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$14M
Income Before Tax	$13M
Income Tax Expense	-$1.1M
Interest And Debt Expense	-
Net Income From Continuing Operations	$14M
Comprehensive Income Net Of Tax	-
Ebit	$14M
Ebitda	$28M
Net Income	$14M

Dividends

Field	Value
Ex Dividend Date	2025-03-17
Declaration Date	2025-03-11
Record Date	2025-03-17
Payment Date	2025-04-07
Amount	0.2

KMDA Profile

Kamada Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
LCID	$2.34	-2.30%	$7.67B	187,389,814
F	$9.68	-4.68%	$39.53B	173,285,336
PTIX	$0.43	91.50%	$4.04M	173,208,693

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
ABBV	$202.45	-1.34%	$364.89B	5,252,004
NVO	$67.60	-0.95%	$308.32B	7,033,051
AZN	$74.03	2.50%	$225.70B	6,150,517

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.19	1,684.81%	$19.91M	117,875
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	20,249,631
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669